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Functional outcome after peroneal nerve injury
Ingrid L. de Bruijna, Jan H. B. Geertzena,b and Pieter U. Dijkstraa,b,c
The objective of this study was to describe muscle
strength, ankle–foot orthosis (AFO) use, walking ability,
participation and quality of life in patients with peroneal
nerve injury. A historic cohort study (n=27) was performed
with a median follow-up time of 61 months (inter quartile
range 37–91). Muscle strength was assessed using the
Medical Research Council scale. Perceived walking ability
was assessed with the Walking Questionnaire. AFO use
and problems in participation were assessed with a
structured interview. The RAND-36 Health Survey was
used to evaluate health-related quality of life. Muscle
strength improved significantly during follow-up but 62%
(16 of 26 patients, one missing value) of the patients still
had paresis to some degree of ankle dorsiflexors. AFO use
decreased significantly but 11% (n=3) still used an AFO
at follow-up. Two-thirds (n=18) of the study population
experienced some limitations in walking and climbing
stairs. Decreased maximum walking distance was reported
by 59 % (n=16). About half of the patients (n=13)
reported some restrictions in leisure activities and 47%
(n=9) of the patients with a paid job (n=19) experienced
some restrictions in work. Scores on the domains physical
functioning, mental health, vitality, bodily pain and general
health perception of the RAND-36 were significantly lower
compared with a Dutch reference group. Limitations in
walking ability and participation are frequently present
5 years after peroneal nerve injury. Health-related quality
of life was lower than in a reference group. International
Journal of Rehabilitation Research 30:333–337 c 2007
Wolters Kluwer Health | Lippincott Williams & Wilkins.
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Introduction
Peroneal nerve injury is the most frequently encountered
mononeuropathy in the lower extremity (Dawson et al.,
1999). It usually presents with flatfoot or drop foot
resulting from weakness of the ankle dorsiflexors. Other
signs are weakness of the foot evertors, and loss of
sensibility of the lateral part of the lower leg and the
dorsum of the foot and pain. The large majority of
peroneal nerve injuries are caused by compression against
the fibular head or by knee trauma (Berry and
Richardson, 1976; Katirji and Wilbourn, 1988).
Deficits and prognosis depend on the extent and type of
the nerve injury. Peripheral nerve injuries are classified
into neurapraxia, axonotmesis and neurotmesis, according
to the actual damage of the nerve and perineurial tissues
(Sunderland, 1978). In neurapraxia, the neural and
perineurial tissues are intact but the conductive function
of the nerve is (temporary) lost or impaired. In axonot-
mesis, the perineurial tissues are intact but the axon is
transected. In neurotmesis, the nerve and perineurial
tissues are completely transected. In general, recovery in
neurapraxia is better than in axonotmesis or neurotmesis.
In neurapraxia and axonotmesis signs of regeneration
are monitored before considering surgical treatment
(Kim and Kline, 1996; Mont et al., 1996; Fabre et al.,
1998; Thoma et al., 2001). In neurotmesis, microsurgical
reconstruction is indicated.
Paresis of ankle dorsiflexors produces gait abnormalities
(Lehmann et al., 1986). An ankle–foot orthosis (AFO) is
usually prescribed when a flatfoot or drop foot exists.
When conservative treatment with an AFO fails and
recovery of the nerve injury is not expected, a tibialis
posterior tendon transposition can be performed to
restore functional dorsiflexion of the ankle (Hove and
Nilsen, 1998; Breukink et al., 2000; Yeap et al., 2001).
Most studies on outcome after peroneal nerve injury
focus on impairments. Only one study was found
describing walking disability and quality of life after
peroneal nerve injury (Aprile et al., 2005). No studies
exist describing restrictions in participation (WHO,
2001). The aim of this historic cohort study was to
describe disability in walking and participation and assess




All patients with one-sided peroneal nerve injury who
visited the Center for Rehabilitation of the University
0342-5282 c 2007 Wolters Kluwer Health | Lippincott Williams & Wilkins
Medical Center Groningen between January 1997 and
November 2004 were selected as potential candidates for
this research. Patients with sciatic nerve injury that
involved solely the peroneal division, confirmed with
electromyography, were also included. Time between
onset of nerve injury and follow-up had to be at least
1 year. Exclusion criteria were: age below 18 years at
onset, additional peripheral neuropathy of the legs,
central neurological disorder, severe visual handicap,
psychiatric disease or mental retardation, lack of under-
standing the Dutch language, being nonambulatory or
using a walking aid before the nerve injury.
Design
Patients with peroneal or sciatic nerve injury were
identified by computer using the International Classifica-
tion of Impairments Diseases and Handicap registration
codes (Ekker, 1980). Data about sex, age, comorbidity
influencing walking ability, affected nerve, side, date of
onset, aetiology, type of nerve injury, AFO use and
surgical treatment were retrieved from the medical
records. Eligible patients were asked by mail to
participate. Nonresponders received a reminder after
4 weeks. The local medical ethics committee was
consulted for this research project but it appeared that
an approval was not obligatory. Patients signed an
informed consent and visited the hospital once. Follow-
up data were collected by means of a structured
interview, physical examination and two questionnaires.
The principal investigator (I.B.) examined all patients.
Measurements
Muscle strength of ankle dorsiflexors and evertors was
assessed using the Medical Research Council scale
(Medical Research Council, 1976). These data were
compared with data at first referral to our out-
patient clinic of the Center for Rehabilitation (UMCG,
Groningen, The Netherlands).
Present AFO use was assessed as well as reasons to stop
AFO use.
Walking ability was assessed with the Walking Ques-
tionnaire, part A, version 1.2 (Roorda et al., 2004, 2005).
This questionnaire is validated, and assesses the per-
ceived limitations in walking inside the house and outside
(35 items) and climbing stairs (15 items) in patients with
lower-extremity disorders who live at home. The items
refer to what persons actually do, not what they think
that they can do. The instrument operationalizes
different aspects of walking such as velocity, adaptations,
difficulty, uncertainty, use of aids and maximal walking
distance. Three scores are calculated: walking inside the
house, walking outside and climbing stairs. Scores range
between 0 (not possible) and 100 (no limitations).
Additionally, three questions were asked about the ability
to walk in darkness, on uneven underground and on
slippery or wet underground. Restrictions in work, leisure
activities, car driving and biking related to the nerve
injury were assessed in a structured interview.
Health-related quality of life (HRQoL) was evaluated
with the RAND 36-item Health Survey, a questionnaire
very similar to the SF-36 (Hays et al., 1993). The RAND-
36 measures nine distinct dimensions of current HRQoL,
that is physical functioning, social functioning, role
limitations owing to physical problems, role limitations
owing to emotional problems, mental health, vitality,
bodily pain, general health perception and health
changes. Scores for each scale range from 0 to 100, with
higher scores indicating higher level of functioning or
well being. The RAND-36 is widely tested and vali-
dated in the Dutch general population. Scores of a
Dutch reference group from the Northern part of the
Netherlands were used for comparison (Van der Zee and
Sanderman, 1993).
Statistical analysis
Data analysis was performed in SPSS version 12.0 for
Windows (htpp://www.spss.com). Data are presented as
means and standard deviation (SD) or as median and
interquartile range (IQR). The Wilcoxon signed-ranks
test was used to analyse changes in muscle strength and
to compare the three scores of the Walking Question-
naire, walking inside the house, i.e. walking outside and
climbing stairs. The McNemar test was used to analyse
changes in AFO use. An independent samples t-test was
performed to analyse the effect of the presence of
comorbidity on scores of the Walking Questionnaire.
A confidence interval analysis was used to compare scores




In total, 128 potential candidates were identified. Fifty
six patients were not eligible: 15 had died, 41 were
excluded because of age (9), additional neurologic
disorder of the legs (20), severe visual handicap (1),
psychiatric disease or mental retardation (3), lack of
understanding the Dutch language (3), having a sig-
nificant pre-existing walking disorder (5). The remaining
72 patients were invited to participate. Twenty-seven
patients (38%) actually participated in this study, 32%
(n=23) refused and the other 30% (n=22) did not
respond. Comparison between nonparticipants and parti-
cipants revealed no significant differences on age, sex and
type of nerve injury. Data on demographics and clinical
characteristics of the study population are presented in
Table 1. The common peroneal nerve was involved in
82% (n=22) of the cases. About half of the nerve injuries
were caused by trauma. Forty-one percent (n=11) of the
patients reported comorbidity affecting their walking
ability. In cases of a drop foot or paresis of the dorsiflexors
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an AFO was prescribed as a rehabilitation therapy to
correct the impairment and to insure the patients to be
able to be more active.
Muscle strength
Muscle strength improved significantly between referral
and follow-up (Table 2). At follow-up 62% (n=16) of our
population still had some paresis. In one conservatively
treated patient assessment of strength of ankle dorsi-
flexors and foot evertors was not possible because of triple
arthrodesis of the ankle joint. All patients with neur-
apraxia regained normal muscle strength of ankle dorsi-
flexors. Of the 14 conservatively treated patients 92%
(n=12) had a MRC score Z 3 of the ankle dorsiflexors
and of the 13 surgically treated patients 77% (n=10).
This difference was not significant.
AFO use
At referral 82% (n=22) of the patients used an AFO, at
follow-up 11% (n=3). This decrease was significant
(P<0.001). A tibialis posterior tendon transposition was
performed in 26% (n=7) of the patients. All seven
stopped using an AFO. Other reasons to stop AFO use
were improvement of active dorsiflexion owing to natural
recovery (n=9), discomfort (n=2) and use of orthopae-
dic shoes (n=1).
Walking ability
Scores on walking inside (median: 94, IQR: 63–100) were
significantly (P<0.001) higher than scores on walking
outside (median: 79, IQR: 42–100) and were significantly
(P=0.007) higher than scores on climbing stairs
(median: 73, IQR: 53–100). In total 63% (n=17) of our
patients experienced some limitations in walking inside
and 67% (n=18) experienced some limitations during
walking outside and climbing stairs. Decreased maximum
walking distance owing to the nerve injury was reported
by 59% (n=16). Eleven percent (n=3) reported a very
limited maximal walking distance of less than 500m.
Scores of patients with comorbidity were statistical
significant lower than the scores of patients without
comorbidity (walking inside the house P=0.013, walking
outside P=0.004, climbing stairs P=0.004). Seventy
percent (n=19) experienced difficulties in walking on
uneven underground, 59% (n=16) had difficulties
walking on a slippery underground and 30% (n=8) had
difficulties walking in the darkness.
Participation
Forty-seven percent (n=9) of the 19 patients with a paid
job experienced some restrictions in work. Work adapta-
tions were reported by two patients. No jobs were lost
because of the nerve injury. Forty-eight percent of the
patients (n=13) reported restrictions in leisure activi-
ties, mostly experienced during sports activities. All 25
patients with a driving license were still able to drive a car
but 32% (n=8) experienced some problems such as
limited endurance in stepping on the gas pedal and
problems in operating the clutch pedal. These problems
were usually solved by adaptations of the car like cruise
control or automatic transmission. Problems in biking
were reported by 19% (n=5) of our population involving
stepping off the bike on the affected side and slipping
from the pedal of the affected foot.




Mean (SD) 45 (14)
Follow-up in months





Common peroneal nerve 82 (22)
Sciatic nerve 7 (2)
Superficial peroneal nerve 7 (2)













Surgical treatmentc 48 (13)
Tibialis posterior tendon transposition 26 (7)
Extirpation tumour 22 (6)
Neurolysis 4 (1)
Primary neuroraphy 15 (4)
Nerve graft 4 (1)
AFO use at referral 82 (22)
Comorbidity affecting walking ability 41 (11)
Arthropathy (hip/knee/ankle) 22 (6)
Muscle damage lower leg 11 (3)
Low back pain 7 (2)
IQR, inter quartile range; AFO, ankle–foot orthosis; SD, standard deviation.
aTotal of percentages exceeds 100% because of rounding off.
bTwo gangliomas, two schwannomas, one neuroma.
cSome patients received more than one surgical treatment.





[% (n)] P valueb
Ankle dorsi-
flexorsc
MRC 0–2 77 (20) 15 (4) 0.001
MRC 3–4 12 (3) 46 (12)
MRC 5 12 (3) 38 (10)
Foot evertors MRC 0–2 62 (16) 27 (7) 0.004
MRC 3–4 19 (5) 31 (8)
MRC 5 19 (5) 42 (11)
MRC, Medical Research Council scale.
aMeasurement of muscle strength was not possible in one patient because of
triple arthrodesis of the ankle.
bComparison of strength at referral and follow-up using Wilcoxon signed-ranks
test.
cTotal of percentages is not 100% because of rounding off.
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Quality of life
Significantly lower scores on the domains physical
functioning, mental health, vitality, bodily pain and
general health perception of the RAND-36 were present
in our patients compared with a Dutch reference group
(Table 3).
Discussion
Muscle strength significantly improved during follow-up
but a substantial part of the patients still had paresis to
some degree of ankle dorsiflexors. AFO use decreased
significantly, 11% still used an AFO at follow-up. About
50% of the patients with a paid job experienced some
restrictions in work and 50% of the study population
reported restrictions in leisure activities. HRQoL was
significant less on five domains of the RAND-36
compared with a reference group.
Improvement in muscle strength was also reported
previously in patients with peroneal nerve injury
(Vastamaki, 1986; Aprile et al., 2000; Thoma et al.,
2001). Percentages of surgically treated patients with
MRC scores of ankle dorsiflexors Z 3 differs between
studies ranging from 61 to 100% (Wilkinson and Birch,
1995; Kim and Kline, 1996; Mont et al., 1996; Fabre et al.,
1998). The percentages of conservatively treated patients
with MRC score of ankle dorsiflexors Z 3 were lower
(45–67%) compared with the percentage we found
(Kim and Kline, 1996; Mont et al., 1996). In these two
studies patients with traumatic nerve injuries and
tumours were included, whereas our population also
included patients with compression injuries that usually
show a better outcome.
In our patients AFO use decreased significantly, from
82 to 11% over time. After tendon transposition (n=7)
all patients stopped using their AFO. Similar results were
reported by others (Hove and Nilsen, 1998; Breukink
et al., 2000; Yeap et al., 2001). After a nerve decompression
none of the patients needed to use an AFO but the
number of drop outs in that study was not described
(Mont et al., 1996).
Two-thirds of our patients perceived some limitations in
walking and climbing stairs. A similar proportion was
found by Aprile et al. (2005). In that study, however, 20%
needed assistance or supervision during walking. We
found less severe limitations in walking. All our patients
could walk independently. The study mentioned was
performed in the early phase, 30–70 days after nerve
injury. Recovery of muscle strength and walking ability of
those patients might be expected. Other explanations for
this difference in walking ability could be adaptation of
our patients to their impairments or treatment of the
drop foot in our patients.
In this study HRQoL was significantly lower in our
patients on the domains physical functioning, mental
health, vitality, bodily pain and general health perception
compared with a reference group. Our patients did not,
however, experience more role limitations owing to
physical or emotional problems. Aprile et al. (2005)
assessed HRQoL in the early phase after peroneal nerve
injury finding lower scores on both physical functioning
and role limitations owing to physical problems. In the
early phase after nerve injury, daily life might be more
disturbed than after 5 years, when patients adapt to their
impairments in a way that it does not interfere with their
role functioning. The scores on the ‘mental status’ were
significantly lower than in the reference group, despite
our exclusion criteria of psychiatric disease or mental
retardation. This can be a result of the fact that most of
our patients had a peroneal nerve injury due to a trauma
(48%) or tumour (19%), so this statistical significance can
be related to the primary reason this nerve injury.
A weakness of this study was the limited number of
patients. Comparison of participants and nonparticipants,
however, showed no significant differences, on age,
sex and type of nerve injury, between the groups. A
considerable number of our patients had comorbidity
affecting walking ability, which influenced the results on
the Walking Questionnaire.
A prospective study with a larger group is needed to
further investigate disability in patients with peroneal
Table 3 Health-related quality of life: scores on domains of the RAND-36
Study population Reference population
Mean difference 95% CIDomains Mean SD Mean SD
Physical function 70.6 24.8 81.9 23.2 11.3 2.4 to 20.2a
Social function 86.6 18.0 86.9 20.5 0.3 –7.5 to 8.1
Role limitations owing to physical problems 75.9 36.3 79.4 35.5 3.5 –10.1 to 17.1
Role limitations owing to emotional problems 88.9 37.0 84.1 32.3 –4.8 –17.2 to 7.6
Mental health 63.1 12.2 76.8 18.4 13.7 6.7 to 20.7a
Vitality 56.3 14.3 67.4 19.9 11.1 3.5 to 18.7a
Bodily pain 54.9 18.3 79.5 25.6 24.6 14.9 to 34.3a
Health perception 55.4 15.5 72.7 22.7 17.3 8.7 to 25.9a
Health change 56.5 20.3 52.4 19.4 –4.1 –11.5 to 3.3
95% CI, 95% confidence interval.
aConfidence interval includes the neutral value of no difference (0): the difference between the groups is significant (Pr0.05).
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nerve injury enabling analysis of subgroups of patients,
but also to study what kind of measurements should be
taken to promote participation and to support quality of
life. On the basis of the results of this study, it is
concluded that muscle strength improves significantly
and AFO use decreases significantly in our patients 5
years after peroneal nerve injury. Limitations in walking
ability and participation are, however, frequently found
and health-related quality of life is lower compared with
the Dutch reference group.
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